Don't Take a Position in Marathon Petroleum Stocks Without Knowing Its Fundamentals!

By Susan Ramirez • Thursday, April 13 09:47 • Permanent Link

Large-cap Energy company Marathon Petroleum has moved -1.3% so far today on a volume of 214,216, compared to its average of 4,020,053. In contrast, the S&P 500 index moved 0.0%.

Marathon Petroleum trades -15.95% away from its average analyst target price of $152.87 per share. The 15 analysts following the stock have set target prices ranging from $139.0 to $165.0, and on average have given Marathon Petroleum a rating of buy.

Anyone interested in buying MPC should be aware of the facts below:

Marathon Petroleum's current price is 21.7% above its Graham number of $105.61, which implies that at its current valuation it does not offer a margin of safety
Marathon Petroleum has moved 49.3% over the last year, and the S&P 500 logged a change of -6.8%
Based on its trailing earnings per share of 28.41, Marathon Petroleum has a trailing 12 month Price to Earnings (P/E) ratio of 4.5 while the S&P 500 average is 15.97
MPC has a forward P/E ratio of 9.3 based on its forward 12 month price to earnings (EPS) of $13.75 per share
The company has a price to earnings growth (PEG) ratio of 0.07 — a number near or below 1 signifying that Marathon Petroleum is fairly valued compared to its estimated growth potential
Its Price to Book (P/B) ratio is 2.1 compared to its sector average of 1.68
Marathon Petroleum Corporation, together with its subsidiaries, operates as an integrated downstream energy company primarily in the United States.
Based in Findlay, the company has 17,800 full time employees and a market cap of $56,740,106,240. Marathon Petroleum currently returns an annual dividend yield of 2.0%.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.